07/06/2026
ASWS attended the EULAR Congress 2026, held in London from 3rd to 6th June.
The congress provided a valuable opportunity to learn, share experiences and connect with the global rheumatology community. We attended several important sessions and discussions and came away with many new ideas and insights.
A proud moment for ASWS was presenting our poster, *"Leveraging Artificial Intelligence to Empower People Living with axSpA in India: A Multilingual Patient-Led Advocacy Initiative."* We were delighted by the positive response it received and the interest shown in the work being done to improve patient education and support through AI.
One of the key highlights was attending the Global Remission Coalition (GRC) meeting, where discussions focused on broadening the definition of remission beyond clinical remission and ensuring that the patient perspective is included. It was encouraging to see the importance being given to what remission truly means to people living with rheumatic diseases.
We also had the opportunity to meet healthcare professionals from both the UK and India and look forward to exploring useful collaborations that can benefit the patient community.
It was interesting to see the many common challenges faced by patient communities in Asia and Africa and to discuss how we can work together, learn from one another and make a greater difference for patients.
The EMEUNET vs PARE Speed Dating session was another highlight, generating many practical and creative ideas on how AI can be used to support patients and patient organisations.
It was particularly heartening to see not only PARE being recognised, but also the wider international patient community. The acknowledgement of the efforts of patient organisations from around the world reflects the growing importance of the patient voice in rheumatology.
We return with new connections, fresh ideas and renewed enthusiasm to continue our work for the axSpA community.